跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OMEPRAZOLE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OMEPRAZOLE
Authorized
STANDARD
OMEPRAZOLE
altamed pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b3eae489ff9f5ebf
Company
altamed pharma
Type
Standard
Approval Details
Approval Id
b3eae489ff9f5ebf
Drug Approval Canada Name
OMEPRAZOLE
Product Name
OMEPRAZOLE
Status
Cancelled Post Market
Status Date
2021-07-27
Original Market Date
2020-03-12
Din
02490692
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC01 OMEPRAZOLE
Atc Name
a 02 bc 01
Aig Number
0121643001
Company Name
altamed pharma
Company Address
151 Boulevard De Mortagne, Boucherville, Quebec, Canada, J4B 6G4
Active Ingredients
OMEPRAZOLE (OMEPRAZOLE MAGNESIUM)
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b3eae489ff9f5ebf
Type
Standard
Back to Health Canada Approvals